These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6846115)

  • 1. Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.
    Lui HK; Lee G; Dhurandhar R; Hungate EJ; Laddu A; Dietrich P; Mason DT
    Am Heart J; 1983 May; 105(5):722-6. PubMed ID: 6846115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study.
    De Soyza N; Shapiro W; Chandraratna PA; Aronow WS; Laddu AR; Thompson CH
    Circulation; 1982 Jun; 65(6):1129-33. PubMed ID: 7042111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
    Chandraratna PA
    Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective treatment of supraventricular arrhythmias with acebutolol.
    Williams DO; Tatelbaum R; Most AS
    Am J Cardiol; 1979 Sep; 44(3):521-5. PubMed ID: 382821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic significance of dosing intervals in beta receptor blocking therapy of hypertension with acebutolol.
    Frick MH; Kala R
    Am J Cardiol; 1981 Nov; 48(5):911-6. PubMed ID: 6118059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acebutolol in supraventricular arrhythmias.
    Aronow WS; Van Camp S; Turbow M; Whittaker K; Lurie M
    Clin Pharmacol Ther; 1979 Feb; 25(2):149-53. PubMed ID: 365429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.
    Singh SN; DiBianco R; Davidov ME; Gottdiener JS; Johnson WL; Laddu AR; Fletcher RD
    Circulation; 1982 Jun; 65(7):1356-64. PubMed ID: 6176357
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of acebutolol and propranolol therapy for ventricular arrhythmias.
    Platia EV; Berdoff R; Stone G; Reid PR
    J Clin Pharmacol; 1985 Mar; 25(2):130-7. PubMed ID: 2580866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias.
    Glasser SP; Clark PI; Laddu AR
    Am J Cardiol; 1983 Nov; 52(8):992-5. PubMed ID: 6195911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of premature ventricular contractions by acebutolol.
    Gradman AH; Winkle RA; Fitzgerald JW; Meffin PJ; Stoner J; Bell PA; Harrison DC
    Circulation; 1977 May; 55(5):785-91. PubMed ID: 66105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The long-term suppression of ventricular arrhythmia by oral acebutolol in patients with coronary artery disease.
    de Soyza N; Kane JJ; Murphy ML; Laddu AR; Doherty JE; Bissett JK
    Am Heart J; 1980 Nov; 100(5):631-8. PubMed ID: 6778183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Properties of acebutolol in twenty patients with cardiac arrhythmias.
    Biron P; Proulx A; Lapointe L; Nadeau R; Tremblay G
    Eur J Clin Pharmacol; 1975; 8(1):11-4. PubMed ID: 1233201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of propafenone in patients with stable ventricular arrhythmias.
    de Soyza N; Terry L; Murphy ML; Thompson CH; Doherty JE; Sakhaii M; Dinh H
    Am Heart J; 1984 Aug; 108(2):285-9. PubMed ID: 6380253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative effects of oral acebutolol and propranolol at rest and during exercise in ischemic heart disease: double-blind placebo crossover study utilizing radionuclide ventriculography.
    Kaul S; Hecht HS; Seidman R; Hopkins J; Singh BN
    Am Heart J; 1984 Sep; 108(3 Pt 1):469-74. PubMed ID: 6382987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of acebutolol and propranolol on premature ventricular complexes.
    Aronow WS; Wong R; Plasencia G; Landa D; Turbow M
    Clin Pharmacol Ther; 1980 Jul; 28(1):28-31. PubMed ID: 6993085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acebutolol for premature ventricular contractions: short- and long-term effects.
    de Soyza N
    Am Heart J; 1985 May; 109(5 Pt 2):1205-9. PubMed ID: 3993536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of premature ventricular complexes with acebutolol.
    Aronow WS; Turbow M; Lurie M; Whittaker K; Van Camp S
    Am J Cardiol; 1979 Jan; 43(1):106-8. PubMed ID: 758758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of acebutolol on cardiac arrhythmias in patients with chronic coronary artery disease.
    Burckhardt D; Raeder EA
    Am Heart J; 1980 Apr; 99(4):443-5. PubMed ID: 6102434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.